Browsing: Drugs

Five neurology-focused startups have together raised around $450 million in the last few weeks. Elsewhere, investors had a muted response to the latest cell therapy research.

Newer insomnia drugs could save society more than $13,000 per person yearly versus older sleep medications, a new Signal49 Research report says.

Under the stars at Banff National Park in Canada, Hannah Sheehan Sauve looked for a sign.

When the FDA was deciding whether to approve the drug Tavneos several years ago to treat a set of rare autoimmune diseases, agency experts argued that would be a mistake